Discriminating Benign and Malignant Brain Tumors By Spectral Analysis of Cerebrospinal Fluid

V. Masilamani *

Masila Research Centre, Thiruppangili-620015, India.

R. Vidhya Shree

Sri Venkateswara Engineering College, Sriperumbudur-602117, India.

Ajay T. Prasad

Department of Neurosurgery, Madras Medical College, Chennai-600002, India.

Kannan Ramamurthy

National Centre for Ultrafast Processes, University of Madras, Chennai-600113, Tamil Nadu, India.

Chellappan Selvaraju

National Centre for Ultrafast Processes, University of Madras, Chennai-600113, Tamil Nadu, India.

Wafa Mohammed Alsaleh

College of Science and Health Professions, King Saud bin Abdulaziz University for Health Science, Saudi Arabia and Department of Physics, College of Science, Hofuf, Saudi Arabia.

Tahani A. Alrebdi

Department of Physics, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box-84428, Riyadh 11671, Saudi Arabia.

Trinka Vijmasi

Masila Research Centre, Thiruppangili-620015, India.

A. Thiruvalluvan

Department of Neurosurgery, Madras Medical College, Chennai-600002, India.

V. Chandramouleeswaran

Department of Neurosurgery, Madras Medical College, Chennai-600002, India.

*Author to whom correspondence should be addressed.


Abstract

The preliminary study is concerned with an innovative technique for the discrimination of malignant brain tumor from benign with reasonable sensitivity and specificity. The entire study is based on the relative fluorescence intensity and life-time of bio-fluorophores like tryptophan and tyrosine which are then validated as a set of ratio parameters. Resultantly, it was seen that malignancy was characterized by three-fold enhancement of tyrosine. The picosecond-time resolved decay time measurement was done, which exhibited two-fold decrease in decay time for malignant sample. The improved accessibility, with minimal invasiveness to the patient, and lower cost are encouraging aspects of this technique.

Keywords: Cerebrospinal fluid (CSF), fluorescence spectra, time resolved spectra, malignant brain tumor, benign brain tumor


How to Cite

Masilamani, V., R. Vidhya Shree, Ajay T. Prasad, Kannan Ramamurthy, Chellappan Selvaraju, Wafa Mohammed Alsaleh, Tahani A. Alrebdi, Trinka Vijmasi, A. Thiruvalluvan, and V. Chandramouleeswaran. 2022. “Discriminating Benign and Malignant Brain Tumors By Spectral Analysis of Cerebrospinal Fluid”. Journal of Pharmaceutical Research International 34 (49A):37-48. https://doi.org/10.9734/jpri/2022/v34i49A36425.

Downloads

Download data is not yet available.